EUVIMEDOpdag EUVIMED
LeserbriefKlinische Studie (Phase II)Open access · CC BY 4.0

Venetoclax combined with daunorubicin and cytarabine (2 + 6) in acute myeloid leukemia: Updated results of a phase II trial

Xiaohui Suo, Zheng Fang, Dongmei Wang, Liyun Zhao, Jie Liu, Hong Li, Xiaojun Ma, Congcong Zhang, Xuemei Zhao, Rui Shi, Yan Wu, Zongjiu Jiao and 12 more

Hematological Oncology · 2024

DOI: 10.1002/hon.3296 ↗

At a glance

Leserbrief in Hematological Oncology, 2024. Written by Xiaohui Suo and 23 co-authors. Institution: Department of Hematology, Handan Central Hospital, Handan, Hebei, China. Major MEDLINE topics: Daunorubicin, Cytarabine, Leukemia, Myeloid, Acute, Sulfonamides. 5 references. The full text is freely available (open access, CC BY 4.0). Funded by: Special project for research and development ability of colleges and universities, National Natural Science Foundation of China, Tianjin Key Medical Discipline Construction Project.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Venetoclax combined with daunorubicin and

Subjects

MeSH terms (MEDLINE)

DaunorubicinCytarabineLeukemia, Myeloid, AcuteSulfonamidesAntineoplastic Combined Chemotherapy ProtocolsBridged Bicyclo Compounds, HeterocyclicHumansMaleFemaleMiddle AgedAgedAdult

Substances

venetoclaxDaunorubicinCytarabineSulfonamidesBridged Bicyclo Compounds, Heterocyclic

Authors and institutions

  • Department of Hematology, Handan Central Hospital, Handan, Hebei, China.
  • Department of Hematology, The Second People's Hospital of Guiyang, Guiyang, Guizhou, China.
  • Department of Hematology, Harrison International Peace Hospital, Hengshui, Hebei, China.
  • Department of Hematology, People Hospital of XingTai, Xing Tai, Hebei, China.
  • Department of Hematology, Sinopharm Tongmei General Hospital, Datong, Shanxi, China.
  • Department of Hematology, Daqing Oilfied General Hospital, Daqing, Heilongjiang, China.

ORCID profiles: Linyu Yuan, Kaiqi Liu

Funding

  • Special project for research and development ability of colleges and universities
  • National Natural Science Foundation of China
  • Tianjin Key Medical Discipline Construction Project
  • Shandong Society of Geriatrics 2021 Annual science and technology Development Plan project

Cite

APA

Suo, X., Fang, Z., Wang, D., Zhao, L., Liu, J., Li, H., Ma, X., Zhang, C., Zhao, X., Shi, R., Wu, Y., Jiao, Z., Song, J., Zhang, L., Li, L., Zhang, S., Lu, X., Yuan, L., Gao, S., …, & Mi, Y. (2024). Venetoclax combined with daunorubicin and cytarabine (2 + 6) in acute myeloid leukemia: Updated results of a phase II trial. Hematological Oncology. https://doi.org/10.1002/hon.3296

Vancouver

Suo X, Fang Z, Wang D, Zhao L, Liu J, Li H, et al. Venetoclax combined with daunorubicin and cytarabine (2 + 6) in acute myeloid leukemia: Updated results of a phase II trial. Hematological Oncology. 2024. doi:10.1002/hon.3296

BibTeX
@article{Suo2024,
  author = {Suo, Xiaohui and Fang, Zheng and Wang, Dongmei and Zhao, Liyun and Liu, Jie and Li, Hong and Ma, Xiaojun and Zhang, Congcong and Zhao, Xuemei and Shi, Rui and Wu, Yan and Jiao, Zongjiu and Song, Jiaojie and Zhang, Ling and Li, Ling and Zhang, Suping and Lu, Xinxiao and Yuan, Linyu and Gao, Sifeng and Zhang, Jilei and Liu, Kaiqi and Zhao, Xingli and Bai, Guanchen and Mi, Yingchang},
  title = {Venetoclax combined with daunorubicin and cytarabine (2 + 6) in acute myeloid leukemia: Updated results of a phase II trial},
  journal = {Hematological Oncology},
  year = {2024},
  doi = {10.1002/hon.3296}
}
Start for free →